Rabeprazole Sodium DR - Award
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
SPE2D2-26-D-0006
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents1
The Defense Logistics Agency (DLA) Troop Support, operating under the Department of Defense, has issued an award notice for the procurement of Rabeprazole Sodium Delayed Release (DR) pharmaceutical products. This contract, identified by procurement number SPE2D2-26-D-0006, is classified under NAICS code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and product service code 6505, indicating drugs and biologicals.
The awarded contract is intended to secure a reliable supply of Rabeprazole Sodium DR, a medication commonly used for the treatment of certain gastrointestinal conditions. The scope of this procurement encompasses the manufacturing and delivery of pharmaceutical-grade Rabeprazole Sodium DR to meet the needs of federal entities, with the place of performance specified as Seymour, Indiana. This location will serve as the primary site for production or distribution activities throughout the contract lifecycle.
DLA Troop Support, as the contracting office, is responsible for overseeing the execution and compliance of this award. The agency’s objective is to ensure the consistent availability of high-quality Rabeprazole Sodium DR for its end users, supporting the broader mission of the Department of Defense to maintain the health and readiness of its personnel.
Key requirements for this contract include adherence to all applicable federal regulations governing pharmaceutical manufacturing, quality assurance standards, and timely delivery schedules. Contractors are expected to maintain rigorous controls over production processes to guarantee product efficacy and safety. The contract documentation, including the award details, is available for review via the official SAM.gov opportunity listing.
For further information or inquiries regarding this award, interested parties may contact the designated representatives at DLA Troop Support. The primary contact is Trong Nguyen (email: [email protected], phone: 445-737-3964), and the secondary contact is Jason Wray (email: [email protected], phone: 445-737-6304).
This award notice remains active as of January 22, 2026, and reflects the agency’s ongoing commitment to sourcing essential pharmaceutical products through transparent and competitive procurement processes. Contractors considering future opportunities in this domain should note the consistent requirements for regulatory compliance, product quality, and reliable supply inherent to federal pharmaceutical contracts.